|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Rossen Donev (Head of Research, MicroPharm Limited, UK) , Rossen Delete Donev (Swansea University, UK) , Rossen Delete Donev (Swansea University, UK) , Rossen Delete Donev (Swansea University, UK)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Volume: 98 Dimensions: Width: 15.20cm , Height: 2.50cm , Length: 22.90cm Weight: 0.750kg ISBN: 9780128028285ISBN 10: 0128028289 Pages: 396 Publication Date: 25 March 2015 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsProtein- and Peptide-Drug Conjugates: An Emerging Drug Delivery Technology Imran Vhora, Sushilkumar Patil, Priyanka Bhatt and Ambikanandan Misra Modifications of Natural Peptides for Nanoparticle and Drug Design Andrew P. Jallouk, Rohun U. Palekar, Hua Pan, Paul H. Schlesinger and Samuel A. Wickline Hybrid Protein–Synthetic Polymer Nanoparticles for Drug Delivery Neli S. Koseva1, Joanna Rydz, Ekaterina V. Stoyanova and Violeta A. Mitova Efficient Delivery of Therapeutic Agents by Using Targeted Albumin Nanoparticles Hasan Kouchakzadeh, Maryam Sadat Safavi and Seyed Abbas Shojaosadati Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery Rebecca Klippstein and David Pozo Implications of Protein- and Peptide-Based Nanoparticles as Potential Vehicles for Anticancer Drugs Ahmed. O. Elzoghby, Mayada. M. Elgohary and Nayra M. Kamel Polysaccharide Nanoparticles for Protein and Peptide Delivery: Exploring Less-Known Materials Marlise Araújo dos Santos and Ana Grenha Bioconjugation of Silk Fibroin Nanoparticles with Enzyme and Peptide and Their Characterization Fei Wang and Yu-Qing Zhang Food-Grade Protein-Based Nanoparticles and Microparticles for Bioactive Delivery: Fabrication, Characterization, and Utilization Gabriel Davidov-Pardo, Iris J. Joye and David Julian McClementsReviewsAuthor InformationRossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications. Tab Content 6Author Website:Countries AvailableAll regions |